Cargando…
Best practices in designing preapproval information engagements for US health care decision makers
As high-cost and innovative therapies continue to enter the market, health care decision makers (HCDMs) are expressing a need for early information on a product’s clinical and economic impacts. Preapproval information exchange (PIE) fulfills these data needs by allowing manufacturers to share drug i...
Autores principales: | Dodda, Sai, Bannister, Breyanne, Hydery, Tasmina, Gorey, Claire, Dunlap, Sarah, Mody, Lorie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387941/ https://www.ncbi.nlm.nih.gov/pubmed/36840953 http://dx.doi.org/10.18553/jmcp.2023.29.3.245 |
Ejemplares similares
-
Methodology for conducting a comprehensive product review in managed care
por: Linnerooth, Sara, et al.
Publicado: (2023) -
Decision makers need an approach to determine digital therapeutic product quality, access, and appropriate use
por: Parcher, Benjamin, et al.
Publicado: (2021) -
Data Empowerment of Decision-Makers in an Era of a Pandemic: Intersection of “Classic” and Artificial Intelligence in the Service of Medicine
por: Geva, Gil A, et al.
Publicado: (2021) -
Examining Tensions That Affect the Evaluation of Technology in Health Care: Considerations for System Decision Makers From the Perspective of Industry and Evaluators
por: Desveaux, Laura, et al.
Publicado: (2017) -
Characteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug Administration
por: Egilman, Alexander, et al.
Publicado: (2021)